Which consortium or company is most economically successful for covid-19 vaccine development?

Transaction logbook for Scott Bugbee

Timestamp	Answer option	Long (for)	Short (against)	Shares	Price %	Action	IP (masked)
2020/11/12 23:30:40 T	BNT162b1: BioNTech, Pfizer	82.96	-	405.89	20.44	Bought	8da0e480
2020/11/12 23:30:00 T	mRNA-1273: Moderna, NIAID	1,893.67	-	8,204.21	23.08	Bought	8da0e480
2020/11/12 23:29:43 T	mRNA-1273: Moderna, NIAID	-80.30	-	359.26	22.35	Sold	8da0e480
2020/11/12 23:29:20 T	BNT162b1: BioNTech, Pfizer	1,103.67	-	5,428.16	20.33	Bought	8da0e480
2020/11/12 23:28:55 T	mRNA-1273: Moderna, NIAID	2,000.00	-	9,167.24	21.82	Bought	8da0e480
2020/11/12 23:28:47 T	One of the 121 other vaccines in development	1,000.00	-	4,801.24	20.83	Bought	8da0e480
2020/11/12 23:28:40 T	AZD1222 (ChAdOx1 nCoV-19): Oxford University, AstraZeneca	2,000.00	-	10,121.04	19.76	Bought	8da0e480
2020/11/12 23:28:24 T	BNT162b1: BioNTech, Pfizer	2,000.00	-	9,952.22	20.10	Bought	8da0e480

O=Opening valuation, M=Market valuation, C=Closing valuation, T=Trade, R=Reversal, S=Settlement